Oculis Holding AG OCS
NASDAQ OCS
$12.18 +0.01 (+0.08%)
As of: Sep 4, 2026 · 3:19 PM EDT

Oculis Holding AG (OCS) Shares Outstanding (Diluted) (2020 - 2026)

Analysis

Oculis Holding AG (OCS) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 66.03 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 210.89 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 115.80 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 138.28 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 556.90 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 217.35 Mn
10 Oculis Holding AG 635.01 Mn 346.13 Mn - 52.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.24 Mn
Mar 31, 2026 52.24 Mn
Dec 31, 2025 52.24 Mn
Sep 30, 2025 40.41 Mn
Jun 30, 2025 40.41 Mn
Mar 31, 2025 40.41 Mn
Dec 31, 2024 40.41 Mn
Sep 30, 2024 29.90 Mn
Jun 30, 2024 29.90 Mn
Mar 31, 2024 29.90 Mn
Dec 31, 2023 29.90 Mn
Sep 30, 2023 3.42 Mn
Jun 30, 2023 3.42 Mn
Mar 31, 2023 3.42 Mn
Dec 31, 2022 3.42 Mn
Sep 30, 2022 2.58 Mn
Jun 30, 2022 2.58 Mn
Dec 31, 2021 2.58 Mn
Dec 31, 2020 2.58 Mn